Literature DB >> 20661827

Adipose tissue accumulation of d-limonene with the consumption of a lemonade preparation rich in d-limonene content.

Jessica A Miller1, Iman A Hakim, Wade Chew, Patricia Thompson, Cynthia A Thomson, H-H Sherry Chow.   

Abstract

d-limonene is a bioactive food component found in high concentration in citrus peel oil with anticancer effects in preclinical studies of mammary carcinogenesis. Extrapolation of preclinical data to human cancer is limited, in part, by inadequate information on the oral bioavailability and tissue disposition of d-limonene in humans. As a fat-soluble compound, d-limonene is more likely to deposit in fatty tissues such as the breast. To assess disposition of d-limonene in humans, we conducted a pilot study of oral d-limonene-rich lemonade. Following a 1-wk washout period devoid of citrus, healthy adults consumed 40 oz. of freshly prepared lemonade containing 500 to 600 mg d-limonene daily for 4 wk. On the first and last consumption days, blood and buttock fat biopsy were collected. Matched preintervention and postintervention fat biopsies (n = 7), and matched preintervention and postintervention plasma samples (n = 6), were analyzed for d-limonene levels using gas chromatography and mass spectrometry. There was a significant increase in d-limonene levels in the fat biopsies after 4 wk (P = 0.009); initial levels ranged from nondetectable to 7.79 micromol/kg tissue, and postintervention levels ranged from 53.6 to 294 micromol/kg tissue. Plasma d-limonene levels increased from 0.35 to 0.72 micromol/l initially to postintervention levels of 0.54 to 1.65 micromol/l (P = 0.016). Postintervention adipose d-limonene levels were 51.0 to 195 times higher than plasma levels (P = 0.009). Our results demonstrate accumulation of d-limonene in adipose tissue after oral dosing and support additional studies of d-limonene for chemoprevention in tissues such as the breast that are comprised of a significant fat fraction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661827      PMCID: PMC6262896          DOI: 10.1080/01635581003693066

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  31 in total

1.  Effect of D-limonene on immune response in BALB/c mice with lymphoma.

Authors:  Susana Del Toro-Arreola; Edgardo Flores-Torales; Carlos Torres-Lozano; Alicia Del Toro-Arreola; Katia Tostado-Pelayo; Maria Guadalupe Ramirez-Dueñas; Adrian Daneri-Navarro
Journal:  Int Immunopharmacol       Date:  2005-01-25       Impact factor: 4.932

2.  Inhibition of DMBA-induced mammary cancer by the monoterpene d-limonene.

Authors:  J A Elegbede; C E Elson; A Qureshi; M A Tanner; M N Gould
Journal:  Carcinogenesis       Date:  1984-05       Impact factor: 4.944

3.  Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines.

Authors:  S Bardon; K Picard; P Martel
Journal:  Nutr Cancer       Date:  1998       Impact factor: 2.900

Review 4.  Chemoprevention and therapy of cancer by d-limonene.

Authors:  P L Crowell; M N Gould
Journal:  Crit Rev Oncog       Date:  1994

5.  Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites.

Authors:  P L Crowell; R R Chang; Z B Ren; C E Elson; M N Gould
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

6.  Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee.

Authors:  D M Vigushin; G K Poon; A Boddy; J English; G W Halbert; C Pagonis; M Jarman; R C Coombes
Journal:  Cancer Chemother Pharmacol       Date:  1998       Impact factor: 3.333

7.  Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras.

Authors:  M N Gould; C J Moore; R Zhang; B Wang; W S Kennan; J D Haag
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

8.  Prevention and therapy of mammary cancer by monoterpenes.

Authors:  M N Gould
Journal:  J Cell Biochem Suppl       Date:  1995

9.  Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2).

Authors:  Ruben R Gonzalez; Salandre Cherfils; Maria Escobar; Jin H Yoo; Cecilia Carino; Aaron K Styer; Brian T Sullivan; Hideo Sakamoto; Alex Olawaiye; Takehiro Serikawa; Maureen P Lynch; Bo R Rueda
Journal:  J Biol Chem       Date:  2006-07-06       Impact factor: 5.157

10.  Effectiveness of combined limonene and 4-hydroxyandrostenedione in the treatment of NMU-induced rat mammary tumours.

Authors:  S K Chander; A G Lansdown; Y A Luqmani; J J Gomm; R C Coope; N Gould; R C Coombes
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

View more
  12 in total

1.  Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention.

Authors:  Jessica A Miller; Kirk Pappan; Patricia A Thompson; Elizabeth J Want; Alexandros P Siskos; Hector C Keun; Jacob Wulff; Chengcheng Hu; Julie E Lang; H-H Sherry Chow
Journal:  Cancer Prev Res (Phila)       Date:  2014-11-11

2.  Dried-leaf Artemisia annua: A practical malaria therapeutic for developing countries?

Authors:  Pamela J Weathers; Melissa Towler; Ahmed Hassanali; Pierre Lutgen; Patrick Ogwang Engeu
Journal:  World J Pharmacol       Date:  2014-12-09

Review 3.  Policy, toxicology and physicochemical considerations on the inhalation of high concentrations of food flavour.

Authors:  Vlad Dinu; Azad Kilic; Qingqi Wang; Charfedinne Ayed; Abdulmannan Fadel; Stephen E Harding; Gleb E Yakubov; Ian D Fisk
Journal:  NPJ Sci Food       Date:  2020-10-07

4.  Safety and Feasibility of Topical Application of Limonene as a Massage Oil to the Breast.

Authors:  Jessica A Miller; Patricia A Thompson; Iman A Hakim; Ana Maria Lopez; Cynthia A Thomson; Wade Chew; Chiu-Hsieh Hsu; H-H Sherry Chow
Journal:  J Cancer Ther       Date:  2012-10

5.  Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer.

Authors:  Jessica A Miller; Julie E Lang; Michele Ley; Ray Nagle; Chiu-Hsieh Hsu; Patricia A Thompson; Catherine Cordova; Amy Waer; H-H Sherry Chow
Journal:  Cancer Prev Res (Phila)       Date:  2013-04-03

Review 6.  Antidiabetic Potential of Monoterpenes: A Case of Small Molecules Punching above Their Weight.

Authors:  Solomon Habtemariam
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

7.  Feasibility and acceptability of a beverage intervention for Hispanic adults: a protocol for a pilot randomized controlled trial.

Authors:  Kristin E Morrill; Benjamin Aceves; Luis A Valdez; Cynthia A Thomson; Iman A Hakim; Melanie L Bell; Jessica A Martinez; David O Garcia
Journal:  Nutr J       Date:  2018-02-09       Impact factor: 3.271

Review 8.  Iridoids and Other Monoterpenes in the Alzheimer's Brain: Recent Development and Future Prospects.

Authors:  Solomon Habtemariam
Journal:  Molecules       Date:  2018-01-07       Impact factor: 4.411

Review 9.  Forest Volatile Organic Compounds and Their Effects on Human Health: A State-of-the-Art Review.

Authors:  Michele Antonelli; Davide Donelli; Grazia Barbieri; Marco Valussi; Valentina Maggini; Fabio Firenzuoli
Journal:  Int J Environ Res Public Health       Date:  2020-09-07       Impact factor: 3.390

10.  Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound-Toward Improved Detection of Liver Impairment.

Authors:  Giuseppe Ferrandino; Isabel Orf; Rob Smith; Marzia Calcagno; Anita Kaur Thind; Irene Debiram-Beecham; Megan Williams; Olga Gandelman; Alexandra de Saedeleer; Graham Kibble; Anne Marie Lydon; Chris A Mayhew; Max Allsworth; Billy Boyle; Marc P van der Schee; Michael Allison; Matthew Hoare; Victoria K Snowdon
Journal:  Clin Transl Gastroenterol       Date:  2020-09       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.